The American Society of Clinical Oncology (ASCO) meeting is scheduled for 1st - 5th June 2012 in Chicago. Apparently, it is a huge event (drawing an estimated 25,000 physicians) and showcases new and emerging procedures in the treatment of cancer.
Whilst researching the ASCO site I came across an Abstract for CVac which can be found at:
http://abstract.asco.org/AbstView_114_100245.html
"A study of autologous dendritic cell therapy targeting muchin-1 for treatment of patients with epithelial ovarian cancer in first remission."
The full Abstract can be found at the link above.
I'm assuming (but I can't confirm from the ASCO site) that a representative from PrimaBiomed will be present during the Category Session - Gynecological Cancer which is scheduled for Sunday, 3rd June 2012 between 8am and 12pm.
This seems to me to be a very positive initiative by Prima and will give the CANVAS trial a higher profile among physicians in the USA and beyond.
Regards,
Goggo
- Forums
- ASX - By Stock
- IMM
- american society of clinical oncology (asco)
american society of clinical oncology (asco)
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
40.0¢ |
Change
0.005(1.27%) |
Mkt cap ! $581.0M |
Open | High | Low | Value | Volume |
38.5¢ | 41.0¢ | 38.5¢ | $1.351M | 3.389M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 16911 | 40.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
40.5¢ | 154170 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 16911 | 0.400 |
6 | 104590 | 0.395 |
6 | 65668 | 0.390 |
6 | 98699 | 0.385 |
10 | 114110 | 0.380 |
Price($) | Vol. | No. |
---|---|---|
0.405 | 154170 | 1 |
0.410 | 259670 | 7 |
0.415 | 187366 | 8 |
0.420 | 484307 | 7 |
0.425 | 69000 | 3 |
Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |